Gowramma Byran

9PUBLICATIONS
9CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and designMolecular targetsCellular nervous systemPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 15, 2026
Computational Identification of Shikimic Acid Derivatives as Potential SARS-CoV-2 Inhibitors: An In Silico Approach.

|Aug 24, 2026
Design and Evaluation of Naphthoxy and Phenoxy amide as Potential PARP 1 inhibitors: Molecular Docking and In Vitro Analysis.

|Aug 24, 2026
Heterocyclic Scaffolds in PARP-1 Inhibition: An Emerging Strategy for Targeted Anticancer Therapy.

|Jul 20, 2026
PARP1 as a Central Node in DNA Repair and Epigenetic Regulation: Implications for Biomarker Discovery and Targeted Therapy in NSCLC.

|Jul 03, 2026
PROTAC-Mediated Targeting of PARP via CRBN: Mechanistic Insights, Resistance Challenges, and Therapeutic Advancements.

|Jan 26, 2026
Role of Poly (ADP-Ribose) Polymerase-1 (PARP1) and Its Inhibitors for Cancer Therapy.

Mettu Omkar Bala Narasimha, Hardha Balachandran, Byran Gowramma

Pageof 2

Frequent Collaborators

6 joint publications

Hardha Balachandran

5 joint publications

Kalirajan Rajagopal

3 joint publications

Kaviarasan Lakshmanan

2 joint publications

Senthil Kumar Murugesan